U-500 insulin (LY041001)

insulin concentrate U-500 (LY041001) · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for U-500 insulin (LY041001), covering 2023-10-18 to 2023-10-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes [Phase 1]